knowledge -WSS

knowledge

author：explore 2025-09-29 01:38:15 - browse：992

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Biotech execs pursue obesity drug boom: ‘It’s the early innings’

hotspot

WSS

Covid hospitalizations on the rise, Humana says

Some of the ways extreme heat will change life as we know it

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Snackable artificial intelligence, expert AI, and the pharma industry

Some of the ways extreme heat will change life as we know it

CDC overhauls leadership of center that led response to Covid

knowledge

knowledge

leisure time

The high cost of giving birth even with insurance

What drug price negotiations mean for Medicare Part D

After affirmative action ruling, medical educators look to 'holistic review'

Stem cell treatment guidelines are released by FDA

Malaria cases in Florida and Texas: Here’s what you need to know

An innovative path out of biotech’s “valley of death”

Novavax promises a turnaround & Lilly roils the obesity market

Snackable artificial intelligence, expert AI, and the pharma industry

Sports medicine is finally prioritizing gender equality

The perfect storm of weather conditions that led to the devastating wildfires in Maui

knowledge

Advances in CAR

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

The history of OxyContin, told through Purdue Pharma documents

Amazon on where the company's health care bets are headed next

Covid's long

A new House health package & hospitals’ new site

focus

hotspot

focus

focus